Owner Daiichi Pharmaceutical Co., Ltd.

Inventors Takemura, Makoto; Miyauchi, Rie; Tanaka, Mayumi; Namba, Kenji; Kawakami, Katsuhiro; Takahashi, Hisashi

Agent Spruson & Ferguson

Pub. Number AU-B-2001232238

PCT Pub. Number WO01/58876

Priority 2000-38099 09.02.00 JP

Filing date 7 February 2001

Wipo publication date 20 August 2001

Acceptance publication date 24 March 2005

C07D 215/56 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 031/4545

A61K 031/5383

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

C07D 453/02 Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 519/00 Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

C07D 498/06 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61P 031/08 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 031/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 031/4995 - Pyrazines or piperazines forming part of bridged ring systems